SurModics, a publicly traded medical-device maker, agreed to acquire Birmingham, Ala.’s Brookwood Pharmaceuticals for $40 million in cash plus milestone payments of up to $22 million. Brookwood develops polymer-based drug formulations. Bloomberg has more here.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More